Hospital treatment for patients with poorly controlled diabetes cost the NHS more than £3bn in avoidable costs in 2017/2018, a study presented at the European Association for the Study of Diabetes’s Annual Meeting in Barcelona, Spain has revealed.
The General Pharmaceutical Council has placed conditions on the supply of medicines by three online pharmacies following patient safety concerns raised during its inspection process.
Pharmaceutical contractor fraud could be costing the NHS in England around £111m each year.
The European Medicines Agency is to start a review of ranitidine medicines after tests revealed that some products contain the impurity N-nitrosodimethylamine.
Gabapentin, pregabalin and oxycodone prescriptions in England increased each year between 2013 and 2018
Prescriptions for gabapentin, pregabalin and oxycodone increased year on year between 2013 and 2018 across primary care in England, study results published in the British Journal of General Practice show.
The General Pharmaceutical Council has rated just six pharmacies as ‘excellent’ following more than 14,500 inspections between August 2013 and November 2018.
The first reusable, propellant-free inhaler is now available for patients with asthma and COPD, in line with NHS plans to reduce its carbon footprint and plastic waste.
Jo Churchill has been appointed as the new parliamentary under-secretary of state for prevention, public health and primary care at the Department of Health and Social Care.
Patients in A&E could be sent to see a community pharmacist instead of a doctor under a future expansion of the scheme that currently refers patients from NHS 111 and general practice.
The NHS has launched a pilot test and treat service for patients who suspect they have a urinary tract infection.
Point-of-care C-reactive protein testing reduces antibiotic use in people with acute COPD exacerbations, a study published in The New England Journal of Medicine has shown.
Researchers have identified a plausible drug–drug interaction between laxatives and non-potassium-sparing diuretics.
Rimegepant, a medicine belonging to a new class of migraine treatments, relieves pain and other symptoms in patients with moderate or severe migraine pain, research published in The New England Journal of Medicine has shown.
Switching inhalers can boost adherenceSubscription
Inhaler switching in asthma and COPD is not associated with negative impacts on patients’ health, study results published in Thorax have shown.
National Institute for Health and Care Excellence guidelines from 2005 may have inadvertently led to increased antidepressant prescribing in children aged under 18 years.
Patients who take tramadol and methadone are at a higher risk of developing hypoglycaemia compared to those who take other opioids, a study has found.
Patients with metastatic colorectal cancer who have a BRAF mutation have improved survival after treatment with three targeted therapies instead of standard chemotherapy, results from a phase III trial have shown.
Customers who buy cannabis from “adult use” dispensaries, where no medical certificate is required, commonly report that they use it for pain relief or to help them sleep.